Jazz Pharmaceuticals (JAZZ) Exchange Rate Effect (2012 - 2026)
Jazz Pharmaceuticals' (JAZZ) quarterly Exchange Rate Effect came in at -$400000.0 in Q1 2026, down 123.53% year-on-year from $1.7 million in Q1 2025, and down 1312.12% quarter-over-quarter from $33000.0 in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Exchange Rate Effect (2012 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at -$400000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect fell 123.53% year-over-year to -$400000.0 in Q1 2026; TTM through Mar 2026 was $4.5 million, a 158.56% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, up 491.34% from the prior year.
- Exchange Rate Effect retreated to -$400000.0 in Q1 2026 per JAZZ's latest filing, from $33000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $4.9 million in Q4 2022 and bottomed at -$5.4 million in Q3 2022.
- The 5-year median for Exchange Rate Effect is $33000.0 (2025), against an average of -$35588.2.
- Across the five-year window, Exchange Rate Effect plunged 2332.35% in 2024 and jumped 708.56% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at $4.9 million in 2022, then plunged by 63.75% to $1.8 million in 2023, then tumbled by 227.95% to -$2.3 million in 2024, then surged by 101.44% to $33000.0 in 2025, then tumbled by 1312.12% to -$400000.0 in 2026.
- Per Business Quant, the three latest JAZZ Exchange Rate Effect figures stand at -$400000.0 (Q1 2026), $33000.0 (Q4 2025), and $203000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Jazz Pharmaceuticals | 15.81 Bn | 13.96 Bn | 934.80 Mn | -400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -400,000.00 |
| Mar 31, 2026 | -400,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Dec 31, 2025 | 33,000.00 |
| Sep 30, 2025 | 203,000.00 |
| Sep 30, 2025 | 203,000.00 |
| Jun 30, 2025 | 4.62 Mn |
| Jun 30, 2025 | 4.62 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Mar 31, 2025 | 1.70 Mn |
| Dec 31, 2024 | -2.29 Mn |
| Dec 31, 2024 | -2.29 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | -759,000.00 |
| Jun 30, 2024 | -759,000.00 |
| Mar 31, 2024 | -1.70 Mn |
| Mar 31, 2024 | -1.70 Mn |
| Dec 31, 2023 | 1.79 Mn |
| Dec 31, 2023 | 1.79 Mn |